APA

Yue X., Zuo Y., Ke H., Luo J., Lou L., Qin W., Wang Y., Liu Z., Chen D., Sun H., Zheng W., Zhu C., Wang R., Wen G., Du J., Zhou B. & Bu X. (20170620). Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. : Biochemical pharmacology.

Chicago

Yue Xin, Zuo Yinglin, Ke Hongpeng, Luo Jiaming, Lou Lanlan, Qin Wenjing, Wang Youqiao, Liu Ziyi, Chen Daoyuan, Sun Haixia, Zheng Weichao, Zhu Cuige, Wang Ruimin, Wen Gesi, Du Jun, Zhou Binhua and Bu Xianzhang. 20170620. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. : Biochemical pharmacology.

Harvard

Yue X., Zuo Y., Ke H., Luo J., Lou L., Qin W., Wang Y., Liu Z., Chen D., Sun H., Zheng W., Zhu C., Wang R., Wen G., Du J., Zhou B. and Bu X. (20170620). Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. : Biochemical pharmacology.

MLA

Yue Xin, Zuo Yinglin, Ke Hongpeng, Luo Jiaming, Lou Lanlan, Qin Wenjing, Wang Youqiao, Liu Ziyi, Chen Daoyuan, Sun Haixia, Zheng Weichao, Zhu Cuige, Wang Ruimin, Wen Gesi, Du Jun, Zhou Binhua and Bu Xianzhang. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. : Biochemical pharmacology. 20170620.